Results 91 to 100 of about 26,012 (179)

Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial. [PDF]

J Clin Hypertens (Greenwich)
Kaciroti N, Levy PD, Jamerson KA, Brook RD.   +3 more
europepmc   +1 more source

Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. [PDF]

Hypertension
Cohen JB, Hossain A, Chittams J, Zhao M, Afable J, Greenip A, Maynard H, Pourmussa B, Prenner SB, Selvaraj S, Townsend RR, Zamani P, Chirinos JA.   +12 more
europepmc   +1 more source

A Case Report of Acute Renal Failure due to Amlodipine Overdose and Alcohol Consumption. [PDF]

Clin Case Rep
Xi Y.
europepmc   +1 more source

Amlodipine monotherapy vs. amlodipine-ARB combination therapy as first-line treatment for primary hypertension: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Pintaningrum Y, Evianto CSP, Ermawan R, Damayanti F, Javier RM, Kurniawan K.   +5 more
europepmc   +1 more source

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). [PDF]

Int J Nephrol Renovasc Dis
Jadhav U, Guha S, Mittal H, Barik C, Gillurkar CS, Gupta SK, Gupta M, Saklecha S, Jadhav M, Choudhari SY, Patil S, Bhushan S, A D, Barkate H.   +13 more
europepmc   +1 more source

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg). [PDF]

Transl Clin Pharmacol
Chang K, Won H, Lee T, Kwon S, Lee SH, Cho JY, Yu KS.   +6 more
europepmc   +1 more source

Hemoadsorption for refractory shock after amlodipine intoxication: a case report. [PDF]

J Med Case Rep
Boavida L, Travassos S, Correia D, Silva D, de Jesus GN.   +4 more
europepmc   +1 more source

Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial. [PDF]

J Clin Hypertens (Greenwich)
Ahn HS, Ahn JC, Cho JM, Lim KH, Han SH, Cho YK, Kim KH, Hong SJ, Lee CJ, Na JO, Sung KC, Choi K, Kim SY, Kim DH, Lee HC, Ihm SH, Youn JC, Choi JY, Kim SH, Kim KI, Sung JH, Pyun WB, Kim WS, Cho JS, Lee Y, Her SH, Cho EJ, Lee EM, Lee HY, Yoon YW, Lee JH, Kim W, Rhee SJ, Shin J.   +33 more
europepmc   +1 more source

Identification of efflux inhibitors through a drug repurposing strategy in <i>Candida albicans</i>. [PDF]

Front Cell Infect Microbiol
Marques D, Costa SS, Rodrigues L.
europepmc   +1 more source

Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study. [PDF]

Transl Clin Pharmacol
Kim SY, Kwak YG, Kim MG, Moon SJ.
europepmc   +1 more source